PDSB
PDS Biotechnology Corp
NASDAQ: PDSB · HEALTHCARE · BIOTECHNOLOGY
$0.97
+1.32% today
Updated 2026-04-30
Market cap
$60.28M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
PDS Biotechnology Corp (PDSB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+12.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+33.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-13.7%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-14.7%
2026-03-26
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-26 | $-0.14 | +20.8% | $0.63 | $0.54 | -14.7% |
| 2025-11-13 | $-0.19 | +9.5% | $0.96 | $0.84 | -12.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.18 | $-0.14 | +20.8% | — | — |
| 2025-09-30 | $-0.21 | $-0.19 | +9.5% | — | — |
| 2025-06-30 | $-0.22 | $-0.21 | +4.5% | — | — |
| 2025-03-31 | $-0.25 | $-0.21 | +14.9% | — | — |
| 2024-12-31 | $-0.28 | $-0.21 | +23.6% | $59066.00 | — |
| 2024-09-30 | $-0.28 | $-0.29 | -3.6% | — | — |
| 2024-06-30 | $-0.34 | $-0.23 | +32.4% | — | — |
| 2024-03-31 | $-0.37 | $-0.30 | +18.9% | — | — |
| 2023-12-31 | $-0.44 | $-0.35 | +20.5% | — | — |
| 2023-09-30 | $-0.45 | $-0.35 | +22.2% | — | — |
| 2023-06-30 | $-0.35 | $-0.37 | -5.7% | — | — |
| 2023-03-31 | $-0.31 | $-0.32 | -3.2% | — | — |
Frequently asked questions
Has PDS Biotechnology Corp beaten earnings estimates?
PDS Biotechnology Corp has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +12.4% over the last 4 quarters.
How does PDSB stock react to earnings?
PDSB stock has moved an average of -13.7% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.